Targeting cancer stem cell pathways for cancer therapy

Abstract

Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been considered promising therapeutic targets for cancer therapy. These cells have self-renewal capacity and differentiation potential and contribute to multiple tumor malignancies, such as recurrence, metastasis, heterogeneity, multidrug resistance, and radiation resistance. The biological activities of CSCs are regulated by several pluripotent transcription factors, such as OCT4, Sox2, Nanog, KLF4, and MYC. In addition, many intracellular signaling pathways, such as Wnt, NF-κB (nuclear factor-κB), Notch, Hedgehog, JAK-STAT (Janus kinase/signal transducers and activators of transcription), PI3K/AKT/mTOR (phosphoinositide 3-kinase/AKT/mammalian target of rapamycin), TGF (transforming growth factor)/SMAD, and PPAR (peroxisome proliferator-activated receptor), as well as extracellular factors, such as vascular niches, hypoxia, tumor-associated macrophages, cancer-associated fibroblasts, cancer-associated mesenchymal stem cells, extracellular matrix, and exosomes, have been shown to be very important regulators of CSCs. Molecules, vaccines, antibodies, and CAR-T (chimeric antigen receptor T cell) cells have been developed to specifically target CSCs, and some of these factors are already undergoing clinical trials. This review summarizes the characterization and identification of CSCs, depicts major factors and pathways that regulate CSC development, and discusses potential targeted therapy for CSCs.

Cited by papers we hold 38

• Petiveria alliacea and Caesalpinia spinosa extracts reduce the generation of cancer-associated fibroblasts in a 3D platform representative of the tumor microenvironment · 2025
  Not checked
• Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy · 2025
  No notice
• Aging and cancer · 2024
  No notice
• Cancer stem cells: advances in knowledge and implications for cancer therapy · 2024
  No notice
• Decoding the spatiotemporal heterogeneity of tumor-associated macrophages · 2024
  No notice
• Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer · 2024
  No notice
• Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease · 2023
  No notice
• Hedgehog signaling in tissue homeostasis, cancers and targeted therapies · 2023
  No notice
• Advances in single-cell RNA sequencing and its applications in cancer research · 2023
  No notice
• Molecular mechanisms of tumor resistance to radiotherapy · 2023
  No notice
• Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment · 2023
  No notice
• Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer · 2023
  No notice
• Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies · 2023
  No notice
• Lessons to cancer from studies of leukemia and hematopoiesis · 2022
  Not checked
• Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients · 2022
  No notice
• Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review · 2022
  Not checked
• Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells · 2022
  Not checked
• LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability · 2022
  No notice
• The CD70-CD27 axis in oncology: the new kids on the block · 2022
  No notice
• Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management · 2022
  No notice

and 18 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.